Anzeige
Mehr »
Donnerstag, 21.08.2025 - Börsentäglich über 12.000 News
US-Start angekündigt: Bisher +175% Kursgewinn in 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40QA7 | ISIN: US80880X1046 | Ticker-Symbol: 4E4
Tradegate
18.08.25 | 20:49
1,020 Euro
+12,71 % +0,115
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SCIENTURE HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
SCIENTURE HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,8450,89520.08.

Aktuelle News zur SCIENTURE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrScienture Holdings, Inc. - 8-K, Current Report1
14.08.Scienture Secures $3.9 Mln Through Registered Direct Stock Offering-
SCIENTURE Aktie jetzt für 0€ handeln
14.08.Scienture stock plummets after announcing $3.9 million registered offering1
14.08.Scienture Holdings, Inc. Announces Pricing of $3.9 Million Registered Direct Offering of Common Stock2
13.08.Scienture Holdings, Inc.: SCIENTURE announces the shipment of launch quantities of Arbli (losartan potassium Oral Suspension) to its 3PL/Distribution Center and receipt of first wholesaler order, marking major commercialization milestones.2
12.08.Scienture Holdings, Inc. - 10-Q, Quarterly Report-
01.08.Scienture files $200M mixed securities shelf3
25.07.Scienture Holdings secures $1.2 million in bridge funding1
24.07.Scienture secures $1.2 million in bridge funding1
24.07.Scienture Holdings, Inc. - 8-K, Current Report1
24.07.Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding1
16.07.Scienture erfüllt wieder NASDAQ-Anforderungen nach Kursanstieg über 1-Dollar-Marke1
16.07.Scienture regains Nasdaq compliance as stock price exceeds $13
16.07.Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements217Commack, NY, July 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the "Company") a holding company for existing and planned pharmaceutical operating companies focused on providing...
► Artikel lesen
03.07.Scienture Holdings, Inc. - 8-K, Current Report1
17.06.Scienture Holdings terminates equity line of credit ahead of product launch2
17.06.Scienture Holdings, Inc.: Scienture Holdings Announces Cancelation of ELOC2
22.05.Scienture appoints Hariharan, Mani as co-CEOs1
22.05.Scienture Holdings, Inc.: SCIENTURE Announces Executive Leadership Transition1
19.05.Scienture Holdings, Inc.: SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL.167TAMPA, FL, May 19, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value...
► Artikel lesen
Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1